BIOCHINA2026: Countdown Begins for Asia’s Largest Biopharma Event!
Market Access Today is proud to be an official promotional partner of BIOCHINA2026, one of Asia’s most anticipated biotechnology and pharmaceutical events.
Following the record-breaking...
BIOCHINA Global Forum @ Boston Successfully Concludes with Nearly 300 Global Biotech Leaders.
— The BIOCHINA Global Forum @ Boston concluded successfully on June 15, drawing nearly 300 attendees from the global biotech and pharmaceutical ecosystem....
London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, Disruptive Tech, Emerging Innovators
London, June 16: In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing...
Historic Move from Trump: Prescription Drug Prices to Be Cut by Up to 80%
Historic Move from Trump: Prescription Drug Prices to Be Cut by Up to 80%
Washington, May 11, 2025 — Former U.S. President Donald J. Trump...
How Trump’s FDA Cuts Are Harming European Drug Access
How Trump’s FDA Cuts Are Harming European Drug Access
The ripple effect of U.S. regulatory setbacks on global medicine approval
The consequences of former U.S. President...
Unlocking the 505(j) Pathway: Strategic Considerations and Regulatory Shifts in 2025
The 505(j) Abbreviated New Drug Application (ANDA) pathway has long served as a cornerstone of the U.S. pharmaceutical regulatory framework. Designed to streamline the...
